N.E.W. Advisory Services LLC Oramed Pharmaceuticals Inc. Transaction History
N.E.W. Advisory Services LLC
- $1.25 Billion
- Q1 2025
A detailed history of N.E.W. Advisory Services LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, N.E.W. Advisory Services LLC holds 18,900 shares of ORMP stock, worth $41,202. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,900
Previous 12,360
52.91%
Holding current value
$41,202
Previous $29,000
37.93%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ORMP
# of Institutions
62Shares Held
8.21MCall Options Held
11.2KPut Options Held
200-
Bml Capital Management, LLC Zionsville, IN3.02MShares$6.59 Million5.23% of portfolio
-
Murchinson Ltd. Toronto, A61.75MShares$3.82 Million0.46% of portfolio
-
Boothbay Fund Management, LLC New York, NY845KShares$1.84 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$798,7542.07% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY252KShares$549,8480.61% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $84.6M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...